Calcitriol Suppliers & Bulk Manufacturers
Available Forms: Capsules & Injection
Available Strengths: Capsules:0.25 mcg, 0.5 mcg; Injection:1 mcg/mL
Reference Brands: Rocaltrol®(EU & US), Calcijex® (US)
Category:
Nephrology
Calcitriol remains a widely used and essential product in renal care and endocrinology, with high demand in hospital, retail, and tender markets. Multiple generic manufacturers operate in the EU and US, making it a key product for B2B distribution, licensing, and contract manufacturing opportunities.
Calcitriol is available in Capsules & Injection
and strengths such as Capsules:0.25 mcg, 0.5 mcg; Injection:1 mcg/mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Calcitriol is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Calcitriol can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Calcitriol is the active form of vitamin D3 used to treat secondary hyperparathyroidism, hypocalcemia, and renal bone disorders in patients with chronic kidney disease (CKD). Approved in both the US and EU, it is available as oral capsules (0.25 mcg, 0.5 mcg) and injectable solution (1 mcg/mL). Calcitriol enhances calcium absorption and suppresses parathyroid hormone (PTH) levels, supporting bone health and mineral balance. Widely prescribed in nephrology and endocrinology, it is a proven and essential therapeutic agent. Calcitriol offers strong B2B potential for licensing, distribution, and hospital tenders in regulated markets with growing CKD and osteoporosis burdens.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing